KURA Stock Charts

Quarterly

Annual

Unit: USD	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2018-09-30	2018-06-30	2018-03-31	2017-09-30	2017-06-30	2017-03-31	2016-09-30	2016-06-30	2016-03-31	2015-09-30	2015-06-30	2015-03-31

revenue
collaboration revenue	20,750,000	15,288,000	14,108,000
total revenue	20,750,000	15,288,000	14,108,000
operating expenses
research and development	67,908,000	62,785,000	55,973,000	52,267,000	41,705,000	39,727,000	36,268,000	32,533,000	29,328,000	28,182,000	25,192,000	22,668,000	24,973,000	24,258,000	20,913,000	20,956,000	22,367,000	21,074,000	20,324,000	17,524,000	16,601,000	13,697,000	12,575,000	13,980,000	11,480,000	11,099,000	11,267,000	6,808,000	5,158,000	5,220,000	4,305,000	3,959,000	3,567,000	3,642,000	3,345,000	2,604,000
general and administrative	32,839,000	25,169,000	22,835,000	24,071,000	18,179,000	16,677,000	18,184,000	14,229,000	13,145,000	11,821,000	11,374,000	12,488,000	11,621,000	11,075,000	11,869,000	12,082,000	11,310,000	12,573,000	10,572,000	8,808,000	7,593,000	7,476,000	7,625,000	8,300,000	4,251,000	3,736,000	3,366,000	2,313,000	2,217,000	2,075,000	1,717,000	1,838,000	2,365,000	1,779,000	1,492,000	1,037,000
total operating expenses	100,747,000	87,954,000	78,808,000	76,338,000	59,884,000	56,404,000	54,452,000	46,762,000	42,473,000	40,003,000	36,566,000	35,156,000	36,594,000	35,333,000	32,782,000	33,038,000	33,677,000	33,647,000	30,896,000	26,332,000	24,194,000	21,173,000	20,200,000	21,230,000	15,982,000	15,276,000	14,991,000	9,499,000	7,930,000	7,653,000	7,058,000	6,791,000	7,040,000	6,428,000	5,907,000	4,688,000
income from operations	-79,997,000	-72,666,000	-64,700,000
yoy
qoq	10.09%	12.31%
operating margin %
other income
interest and other income	6,274,000	6,935,000	7,879,000	5,659,000	5,892,000	5,973,000	5,325,000	4,370,000	4,275,000	3,216,000	2,861,000	2,271,000	1,090,000	564,000	329,000	295,000	311,000	290,000
interest expense	-393,000	-391,000	-382,000	-403,000	-412,000	-406,000	-398,000	-394,000	-404,000	-387,000	-364,000							-306,000	-108,000	-144,000	-146,000	-144,000	-144,000	197,000	-252,000	-267,000	-258,000	-226,000	-209,000	-203,000	-194,000	-189,000				-42,000
total other income	5,881,000	6,544,000	7,497,000	5,256,000	5,480,000	5,567,000	4,927,000	3,976,000	3,871,000	2,829,000	2,497,000	2,042,000	1,090,000	564,000	329,000	295,000	311,000	-16,000	202,000	173,000	425,000	686,000	990,000	2,440,000	975,000	537,000	387,000	166,000	110,000	120,000	132,000	130,000	414,000	338,000	322,000	212,000
income before income taxes	-74,116,000	-66,122,000	-57,203,000
income tax expense			226,000
net income	-74,116,000	-66,122,000	-57,429,000	-19,217,000	-54,404,000	-50,837,000	-49,525,000	-42,786,000	-38,602,000	-37,174,000	-34,069,000	-33,114,000	-35,504,000	-34,769,000	-32,453,000	-32,743,000	-33,366,000	-33,663,000	-30,694,000	-26,159,000	-23,769,000	-20,487,000	-19,210,000	-18,790,000	-15,007,000	-14,739,000	-14,604,000	-9,333,000	-7,820,000	-7,533,000	-6,926,000	-6,661,000	-6,626,000	-6,090,000	-5,585,000	-4,476
yoy	36.23%	30.07%	15.96%	-55.09%	40.94%	36.75%	45.37%	29.21%	8.73%	6.92%	4.98%	1.13%	6.41%	3.29%	5.73%	25.17%	40.38%	64.31%	59.78%	39.22%	58.39%	39.00%	31.54%	101.33%	91.91%	95.66%	110.86%	40.11%	18.02%	23.69%	24.01%	148715.91%
qoq	12.09%	15.14%	198.84%	-64.68%	7.02%	2.65%	15.75%	10.84%	3.84%	9.11%	2.88%	-6.73%	2.11%	7.14%	-0.89%	-1.87%	-0.88%	9.67%	17.34%	10.06%	16.02%	6.65%	2.24%	25.21%	1.82%	0.92%	56.48%	19.35%	3.81%	8.76%	3.98%	0.53%	8.80%	9.04%	124676.59%
net income margin %
net income per share	-0.85	-0.75	-0.66	-0.22	-0.63	-0.59	-0.59	-0.55	-0.5	-0.53	-0.5	-0.49	-0.53	-0.52	-0.49	-0.5	-0.5	-0.51	-0.46	-0.45	-0.42	-0.4	-0.42	-0.21	-0.4	-0.45	-0.46	-0.38	-0.4	-0.39	-0.37	-0.36	-0.36	-0.57	-0.54	-1.41
weighted-average number of shares used in computing net income per share, basic and diluted	87,645	87,586	87,415	86,161	86,950	86,635	83,905	73,229	77,241	69,795	68,403	66,990	66,889	66,672	66,607	66,352	66,353	66,282	66,218	53,077	56,405	51,633	45,411	41,946	37,789	32,971	31,829	24,344	19,789	19,464	18,850	18,548	18,245	10,723	10,420	3,184
comprehensive loss	-73,909	-66,385	-57,219	-19,569	-52,825	-50,484	-49,070	-40,522	-36,915	-36,500	-31,933	-31,730	-37,105	-35,936	-37,312	-34,338	-33,167	-33,974	-30,822	-26,337	-24,102	-20,491	-18,980	-18,254	-15,037	-14,764	-14,623	-9,325	-7,823	-7,534	-6,960	-6,627	-6,528	-6,075	-5,599
other comprehensive income																								-18.5	-30
unrealized gain on short-term investments	207	-263	210
operating expenses:
other income:
comprehensive loss:
other comprehensive income:
unrealized gain on marketable securities				596.75	1,579	353	455																					8	-3	-1	-34	34	98	15
balance at december 31, 2023				279,994	74,350	74,350	74,350
issuance of pre-funded warrants to purchase common stock, net of offering costs				30,681.5				8,164.5
issuance of common stock, net of offering costs				5,771.75	1,377	1,377	1,377	-59,549	5,661	5,661										-127,186	10,465
share-based compensation expense				2,128				1,709.5				4,878.25				4,295.5				2,266.25					6,938	4,415	2,179	3,099	1,924	894	1,503	919	490	1,663	1,129	644
issuance of common stock under equity plans				638.75	454	454	454		125	125	125	-2,834	322	266
balance at march 31, 2024				319,214	76,181	76,181	76,181
balance at june 30, 2024				322,081.5	76,422	76,422
exercise of pre-funded warrants					1,000
balance at september 30, 2024				324,713	77,749
unrealized gain on marketable securities and foreign currency								2,264	1,687	674	2,136	-1,906.75	-1,601			-1,595	199	-311	-128	-178	-333	-4	230
common stock
shares
balance at december 31, 2022								249,277.75	68,314	68,314	68,314
balance at march 31, 2023								250,987.25	68,439	68,439	68,439
balance at june 30, 2023								276,236	74,143	74,143
balance at september 30, 2023								278,029.5	74,251
balance at december 31, 2021												235,339.75	66,572	66,572	66,572
other comprehensive loss																										-25	-19
balance at september 30, 2022												241,181	66,894
other comprehensive loss:
unrealized loss on marketable securities and foreign currency														-1,167	-4,859
balance at june 30, 2022														66,838
issuance of common stock under equity incentive plan															64
balance at march 31, 2022															66,636
balance at december 31, 2020																-847,160	66,194	66,194	66,194
issuance of common stock from exercises of options and employee stock purchase plan																908	310	102
balance at september 30, 2021																233,542	66,504
balance at june 30, 2021																		66,296
management fee income, related party																			8,000	12,000	12,000	12,000	15,000	-310,000	180,000	180,000	195,000	195,000	195,000	195,000	195,000	195,000	300,000	300,000	300,000	300,000
interest income																			302,000	305,000	559,000	818,000	1,119,000	2,553,000	1,047,000	624,000	450,000	197,000	124,000	128,000	131,000	124,000	114,000	38,000	22,000
issuance of common stock from exercise of options																			69
balance at march 31, 2021																			66,263
balance at december 31, 2019																				-385,938	45,384
issuance of common stock from exercise of options and employee stock purchase plan																				-7,104	778
balance at september 30, 2020																				145,652	56,627
research and development, related party																								214,250	181,000	377,000	299,000	334,000	494,000	293,000	1,011,000	977,000	1,082,000	993,000	1,056,000	1,024,000
general and administrative, related party																								48,250	70,000	64,000	59,000	44,000	61,000	65,000	25,000	17,000	26,000	14,000	14,000	23,000
operating activities
adjustments to reconcile net income to net cash from operating activities:
non-cash interest expense																									167	114	57	62	32	16	27	11
depreciation expense																									10	9	5	23	16	8	23	15	8	13	6	3
amortization of premium and accretion of discounts on marketable securities																									-1,299	-703	-275
changes in operating assets and liabilities:
accounts receivable, related party																									-16	-14	-41	86	-9	-46	169	144	24	-349	-342	-318
prepaid expenses and other current assets																									-1,282	-1,026	-624	-184	-462	-409	-193	-352	-510	-644	-778
other long-term assets																									-355	-42	-163	-205	-117	-288	-223	51	74	-288	-129
accounts payable and accrued expenses																									1,537	814	440	1,173	-502	-1,088	-26	-882	-1,097	2,561	1,382	90
accounts payable and accrued expenses, related party																									38	221	117	-428	-373	-342	151	117	258		978
other long-term liabilities																									168	112	58	166	109	147	52	22		-999	-998
net cash from operating activities																									-38,444	-25,443	-12,851	-20,967	-14,732	-8,622	-18,611	-13,139	-7,314	-12,320	-7,890	-4,123
investing activities
purchases of marketable securities																									-203,461	-106,850	-76,207	-79,254	-19,360	-10,543	-41,207	-23,445	-4,003	-30,129	-26,260
maturities of marketable securities																									119,543	80,993	46,493	59,927	36,327	20,077	43,705	25,800	12,200
net cash from investing activities																									-83,918	-25,857	-29,714	-19,327	16,967	9,534	2,498	2,355	8,197	-30,178	-26,287	-10
financing activities
proceeds from issuance of common stock																									132,170	57,650	57,650	53,683	159					47,586	47,841	51,580
proceeds from exercise of stock options																									327	125		222	35	5
repayment of long-term debt																									-1,000	-250
net cash from financing activities																									131,497	57,525	57,650	53,905	194	5	7,453	7,453		52,589	52,841	56,580
net increase in cash and cash equivalents																									9,135	6,225	15,085	13,611	2,429	917	-8,660	-3,331	883	10,091	18,664
cash and cash equivalents at beginning of period																									11,433	11,433	11,433	9,725	9,725	9,725	15,443	15,443	15,443	1,124	1,124
cash and cash equivalents at end of period																									20,568	17,658	26,518	23,336	12,154	10,642	6,783	12,112	16,326	11,215	19,788
amortization of discount on marketable securities																												-73	3	19	119	103	65	104	37
proceeds from issuance of long-term debt																															7,453	7,453
supplemental disclosure of cash flow information:
interest paid																												466	305	148
interest expense, related party																																				-46,000
non-cash license fee expense																																		500	500	500
change in value of derivative liability																																		268	307
non-cash interest expense, related party
purchases of property and equipment																																		-49	-27	-10
proceeds from issuance of convertible notes payable																																		5,000	5,000	5,000
proceeds from issuance of convertible notes payable, related party
proceeds from issuance of restricted stock awards																																		3
supplemental disclosure of non-cash financing activities:
conversion of convertible notes and related accrued interest to common stock																																		4,327	4,327	4,327
conversion of convertible notes and related accrued interest to common stock, related party																																		3,288	3,288	3,288
financing costs included in accounts payable and accrued expenses																																			253	3,535
non-cash accrued interest expense																																		37	37	37
non-cash accrued interest expense, related party																																		42
long-term liabilities
accounts payable, related party																																		923		927
proceeds from issuance of notes payable, related party
unrealized loss on marketable securities																																			-14
non-cash accrued interest expense, related parties																																			42	41
net income and comprehensive loss																																				-4,476,000
prepaid expenses																																				-664
other liabilities																																				-907
net increase in cash																																				52,447
cash at beginning of period																																				1,124
cash at end of period																																				53,571

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.